Delisting risk
Enveric Biosciences (ENVB)
Develops non-hallucinogenic neuroplastogenic medicines for psychiatric and neurological disorders.
$1.44
Pre-market+0.02 (+1.77%)
At close$1.42(+3.28%)
Something off on this page? Send us feedback.
Breakdown13F · 13D/G · Form 4
| Institutions11 holders · as of Mar 31, 2026 | 9.21% | 55.0K shares | |
| Insiders8 holders · as of Dec 30, 2025 | 26.98% | 161.1K shares | |
| Strategic holders1 holder · as of Aug 14, 2026 | 67.85% | 405.1K shares | |
| Adds to | 104.04% |
597.0K company shares as of Aug 31, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing
Two share counts disagree (4.48M in the company's Sep 3, 2026 report, 597.0K elsewhere); stakes use the report.
These groups come from separate filings that can overlap, so they add to 104.04%; nothing is left for Other.
Institutions13F, as of Mar 31, 2026
11 holders · 55.0K shares · 2 new positions · 4 increased · 1 reduced · 2 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Geode Capital Management, LLC | 32.1K | 5.38% | +32.1Knew | May 15, 2026 |
| Advisorshares Investments LLC | 17.0K | 2.84% | 0 | Apr 28, 2026 |
| UBS Group AG | 3.6K | 0.61% | +717 | May 5, 2026 |
| Tower Research Capital LLC (TRC) | 1.1K | 0.18% | −814 | May 15, 2026 |
| Jones Financial Companies LLLP | 1.0K | 0.17% | +1.0Knew | May 15, 2026 |
| Sbi Securities Co., Ltd. | 83 | 0.01% | +34 | Apr 28, 2026 |
| BlackRock, Inc. | 51 | 0.01% | 0 | May 13, 2026 |
| Group One Trading, L.P. | 1 | 0.00% | 0 | May 13, 2026 |
Ownership statements13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Armistice Capital, LLC | 9.99% | 405.1K | 13G | Aug 14, 2026 ↗ |
| Ayrton Capital LLC | 9.99% | 13G | Nov 13, 2025 ↗ | |
| Lind Global Fund III LP | 7.76% | 158.7K | 13G | May 15, 2026 ↗ |
Insider tradesForm 4
Latest trades
No open-market trades in the last 12 months.
CongressHouse and Senate disclosures
Not reported.